| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| April 1, 2026 | ±2.8% | -15.5% | under-priced |
| December 30, 2025 | ±2.6% | -0.0% | over-priced |
| October 1, 2025 | ±2.1% | +6.4% | under-priced |
| April 3, 2025 | ±2.8% | -14.4% | under-priced |
| January 3, 2025 | ±2.5% | -0.5% | over-priced |
| October 7, 2024 | ±3.5% | -1.7% | over-priced |
| April 4, 2024 | ±1.9% | -1.4% | over-priced |
| January 5, 2024 | ±2.3% | -0.2% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q3 FY2026 | $0.35 | $11.3B | $520M |
| Q2 FY2026 | $0.53 | $12.4B | $792M |
| Q1 FY2026 | $0.49 | $11.7B | $727M |
| Q4 FY2025 | $0.14 | $11.1B | $211M |
Nike, Inc. (NKE) reports in 40 days, with the next report estimated for July 23, 2026. Across the last 8 reports, options priced an average ±2.6% earnings move while the stock actually moved 5.0% on average — the market has been roughly fair on NKE's earnings risk. Fundamentals into the print: EPS down 35.2% year-over-year, revenue up 0.1%. QuantLogix's live 5-factor engine currently reads NKE as a buy at 51/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →